查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1896227

基於營養基因組學的膳食補充劑市場預測至2032年：按補充劑類型、個人化方法、分銷管道、最終用戶和地區分類的全球分析

Nutrigenomics-Based Supplements Market Forecasts to 2032 - Global Analysis By Supplement Type, Personalization Approach, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的一項研究，全球基於營養基因組學的補充劑市場預計到 2025 年將價值 18 億美元，到 2032 年將達到 55 億美元。

基於營養基因組學的營養補充劑是一種旨在透過利用個體基因組成資訊來最佳化代謝功能、營養利用率和整體健康的營養產品。它們是基於DNA分析，以了解特定基因如何影響人體對維生素、礦物質、抗氧化劑和生物活性化合物的反應。根據與發炎、解毒、代謝、營養吸收等相關的基因標記，營養補充劑會根據每個人的生物需求進行客製化，而不是採用千篇一律的方法。這種個人化策略旨在透過將營養配方與每個人的獨特基因譜相匹配，來改善健康、預防營養缺乏、增強健康水平並降低患病風險。

人們越來越意識到基因與飲食之間的相互作用

消費者越來越意識到遺傳傾向會影響營養吸收、新陳代謝和整體健康。這種日益成長的意識推動了對根據個人基因譜量身定做的營養補充劑的需求，從而提供更精準有效的解決方案。個人化營養正受到注重健康的消費者的青睞，他們尋求的是針對性的干涉措施，而非千篇一律的產品。強調基因與飲食之間聯繫的行銷宣傳活動和科學論文進一步激發了消費者的興趣。因此，對基因與飲食相互作用的認知正在成為市場擴張的主要驅動力。

營養基因組學聲明缺乏明確的監管規定

許多保健品都宣稱具有基因個人化功效，但監管機構往往缺乏標準化的框架來檢驗這些說法。這種模糊性給製造商帶來了挑戰，使他們難以在不同地區以可信且一致的方式進行產品定位。消費者對未經證實的說法持懷疑態度，減緩了產品的普及，尤其是在風險規避型人群中。檢驗的不不確定性也使企業因擔心合規風險而不敢進行大規模商業化投資。因此，監管不明朗仍然是產品廣泛市場滲透的一大障礙。

營養基因體學研究與分析技術的進展

基因定序技術的快速發展使DNA檢測更加經濟實惠，也更容易被消費者接受。這些進步使得精準識別與營養代謝相關的遺傳標記成為可能，推動了消費者對個人化營養補充品的需求。人工智慧和巨量資料分析的融合進一步提高了建議的準確性，增強了消費者的信任。研究機構和生技公司正與營養補充品公司進行越來越多的合作，共同開發實證產品。這項科學進步與消費者對個人化和透明化健康解決方案的需求不謀而合。

臨床證據不足以支持產品有效性

基因檢測雖然能夠幫助我們了解體質傾向，但許多營養補充品配方缺乏可靠的臨床試驗來證明其有效性。這種差距降低了消費者的信任度，也限制了尋求實證建議的醫療保健專業人員的採納。長期研究的缺乏進一步限制了安全性和持續有效性的檢驗。提供療效確切的傳統營養補充劑的競爭對手給營養基因組學產品帶來了更大的壓力。如果沒有更強力的臨床支持，基於營養基因組學的營養補充劑可能會被視為小眾產品或實驗性產品。

新冠疫情的影響

新冠疫情對營養基因組學補充劑市場產生了複雜的影響。供應鏈中斷導致產品上市延遲，基因檢測服務取得受限，減緩了多個地區的普及速度。疫情期間，經濟的不確定性也降低了消費者對高階個人化補充品的支出。然而，疫情也提高了人們對免疫力、營養和預防保健的認知，重新激發了人們對個人化解決方案的興趣。由於實體診所面臨諸多限制，提供居家DNA檢測和補充劑配送服務的線上平台獲得了更多關注。

預計在預測期內，維生素和礦物質細分市場將佔據最大的市場佔有率。

在預測期內，維生素和礦物質細分市場預計將佔據最大的市場佔有率，這主要得益於其廣泛的消費群以及在營養領域的穩固​​地位。營養基因體學透過根據遺傳傾向客製化補充劑，提高吸收率和功效，從而為該品類增添價值。存在營養缺乏或基因突變的消費者可從針對性維生素和礦物質配方中獲益，從而推動市場需求。價格實惠以及在零售和線上通路的廣泛供應進一步鞏固了該細分市場的主導地位。為了在成熟的類別中脫穎而出，製造商正利用基於DNA的個人化技術進行創新。人們對基因與飲食之間相互作用的認知不斷提高，也進一步增強了個人化維生素和礦物質產品的吸引力。

預計在預測期內，基於DNA的個人化客製化領域將呈現最高的複合年成長率。

在預測期內，基於DNA的個人化產品細分市場預計將實現最高成長率，因為基因檢測技術的進步使得DNA分析更加便捷，並且能夠提供精準的營養補充建議。尤其年輕的科技達人消費者對基於DNA的個人化產品青睞有加，因為他們重視創新和客製化。人工智慧驅動的分析技術的應用提高了準確性，並增強了消費者對個人化產品的信任。生技公司與營養品公司之間的合作加速了產品研發，也促進了該細分市場的成長。強調產品獨特性和科學性的行銷宣傳活動正在推動其進一步普及。

比最大的地區

預計在預測期內，北美地區將佔據最大的市場佔有率，這主要得益於消費者對個人化營養的強烈認知。該地區受益於基因檢測服務的廣泛應用和成熟的營養補充劑市場。美國和加拿大的消費者對以科學為導向的健康解決方案接受度很高，這鞏固了該地區的主導地位。大型生物技術公司和營養基因組學Start-Ups的存在正在加速創新和商業化進程。儘管法律規範仍在不斷完善，但與其他地區相比，其提供的指南相對清晰，有利於相關技術的推廣應用。較高的可支配收入和對高階健康產品的投資意願進一步增強了市場需求。

預計年複合成長率最高的地區

由於人們對預防性醫療保健的興趣日益濃厚，預計亞太地區在預測期內將實現最高的複合年成長率。中國、印度和日本等國家年輕族群對個人化營養補充劑的需求不斷成長。不斷壯大的中產階級和日益成長的可支配收入推動了高級產品的普及。政府為促進醫療保健和營養領域的創新而採取的措施進一步推動了需求。電子商務平台使基於營養基因組學的營養補充劑在各個市場更容易取得。人們對基因與飲食之間相互作用的認知不斷提高，正在加速此類產品的普及，尤其是在都市區。

免費客製化服務

所有購買此報告的客戶都將獲得以下免費自訂選項之一：

  • 公司概況
    • 最多三家新增市場參與企業進行全面分析
    • 主要參與企業（最多3家公司）的SWOT分析
  • 區域細分
    • 根據客戶要求，對主要國家進行市場估算和預測，並計算複合年成長率（註：可行性需確認）。
  • 競爭基準化分析
    • 從產品系列、地域覆蓋範圍和策略聯盟等方面對主要參與企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 摘要
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球營養基因體學膳食補充品市場（依補充劑類型分類）

  • 維生素和礦物質
  • 益生菌和益生元
  • Omega-3脂肪酸和健康脂肪
  • 蛋白質和胺基酸
  • 特殊營養補充品
  • 其他

6. 全球以營養基因體學為基礎的個人化膳食補充劑市場

  • 基於DNA的個性化
  • 基於微生物組的個人化
  • 生活方式和環境數據的整合
  • 基於人工智慧/機器學習演算法的個人化
  • 其他

7. 全球營養基因組學補充品市場（按分銷管道分類）

  • 直接面對消費者 (D2C) 平台
  • 藥房和藥品商店
  • 專業營養品店
  • 網路市集
  • 其他

8. 全球以營養基因體學為基礎的補充劑市場（按最終用戶分類）

  • 千禧世代與Z世代
  • X世代
  • 嬰兒潮世代
  • 其他

9. 全球營養基因體學補充市場（按地區分類）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章：重大進展

  • 協議、夥伴關係、合作和合資企業
  • 併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第11章 企業概況

  • Nutrigenomix
  • DNAfit Life Sciences
  • Genova Diagnostics
  • GX Sciences
  • Metagenics
  • Thorne HealthTech
  • LifeGenomics
  • GenePlanet
  • MyDNA
  • Toolbox Genomics
  • Vitagene
  • DayTwo
  • Habit Personalized Nutrition
  • Persona Nutrition
Product Code: SMRC32915

According to Stratistics MRC, the Global Nutrigenomics-Based Supplements Market is accounted for $1.8 billion in 2025 and is expected to reach $5.5 billion by 2032 growing at a CAGR of 16.8% during the forecast period. Nutrigenomics-based supplements are nutrition products designed using insights from a person's genetic makeup to optimize metabolic functions, nutrient utilization, and overall health. They rely on DNA analysis to understand how specific genes influence responses to vitamins, minerals, antioxidants, and bioactive compounds. Based on these genetic markers-such as those related to inflammation, detoxification, metabolism, and nutrient absorption-supplements are customized to support individual biological needs rather than a one-size-fits-all approach. This personalized strategy aims to improve health outcomes, prevent deficiencies, enhance wellness, and reduce disease risks by aligning nutrient formulations with each person's unique genetic profile.

Market Dynamics:

Driver:

Growing awareness of gene-diet interaction

Consumers are increasingly recognizing that genetic predispositions influence nutrient absorption, metabolism, and overall health outcomes. This awareness is fueling demand for supplements tailored to individual genetic profiles, offering more precise and effective solutions. Personalized nutrition is gaining traction among health-conscious populations who seek targeted interventions rather than generic products. Marketing campaigns and scientific publications highlighting gene-diet links are further accelerating consumer interest. As a result, gene-diet awareness is emerging as a primary driver of market expansion.

Restraint:

Limited regulatory clarity for nutrigenomic claims

Many supplements are marketed with genetic personalization benefits, but regulatory bodies often lack standardized frameworks to validate these claims. This ambiguity creates challenges for manufacturers in positioning products credibly and consistently across regions. Consumer skepticism about unverified claims slows adoption, particularly among risk-averse populations. Regulatory uncertainty also discourages investment in large-scale commercialization, as companies fear compliance risks. Consequently, limited regulatory clarity remains a significant restraint to widespread market penetration.

Opportunity:

Advancements in nutrigenomics research and analytics

Rapid progress in genetic sequencing technologies has made DNA testing more affordable and accessible to consumers. These advancements enable precise identification of genetic markers linked to nutrient metabolism, driving demand for personalized supplements. Integration of AI and big data analytics further enhances the accuracy of recommendations, strengthening consumer trust. Research institutions and biotech firms are increasingly collaborating with supplement companies to develop evidence-based products. This scientific progress aligns with consumer demand for personalization and transparency in health solutions.

Threat:

Insufficient clinical evidence supporting product efficacy

While genetic testing provides insights into predispositions, many supplement formulations lack robust clinical trials to prove effectiveness. This gap reduces consumer confidence and limits adoption among healthcare professionals who demand evidence-based recommendations. The absence of long-term studies further restricts validation of safety and sustained benefits. Competitors offering traditional supplements with established efficacy create additional pressure on nutrigenomics products. Without stronger clinical backing, nutrigenomics supplements risk being perceived as niche or experimental.

Covid-19 Impact:

The COVID-19 pandemic had a mixed impact on the Nutrigenomics-Based Supplements market. Supply chain disruptions delayed product launches and restricted access to genetic testing services, slowing adoption in several regions. Economic uncertainty also reduced consumer spending on premium personalized supplements during the crisis. However, the pandemic heightened awareness of immunity, nutrition, and preventative health, driving renewed interest in personalized solutions. Online platforms offering at-home DNA testing and supplement delivery gained traction as physical clinics faced restrictions.

The vitamins & minerals segment is expected to be the largest during the forecast period

The vitamins & minerals segment is expected to account for the largest market share during the forecast period due to its broad consumer base and established role in nutrition. Nutrigenomics enhances this category by tailoring supplementation to genetic predispositions, improving absorption and efficacy. Consumers with deficiencies or genetic variations benefit from targeted vitamin and mineral formulations, reinforcing demand. The segment's dominance is further supported by its affordability and widespread availability across retail and online channels. Manufacturers are innovating with DNA-based personalization to differentiate offerings within this established category. Rising awareness of gene-diet interaction strengthens the appeal of personalized vitamins and minerals.

The DNA-based personalization segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the DNA-based personalization segment is predicted to witness the highest growth rate owing to advances in genetic testing have made DNA analysis more accessible, enabling precise supplement recommendations. Younger demographics and tech-savvy consumers are particularly drawn to DNA-based personalization, valuing innovation and customization. Integration of AI-driven analytics enhances accuracy, reinforcing consumer trust in personalized products. The segment benefits from partnerships between biotech firms and supplement companies, accelerating product development. Marketing campaigns emphasizing uniqueness and scientific credibility further boost adoption.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share driven by strong consumer awareness of personalized nutrition. The region benefits from widespread availability of genetic testing services and established supplement markets. Consumers in the United States and Canada are highly receptive to science-driven wellness solutions, reinforcing regional leadership. The presence of leading biotech firms and nutrigenomics startups accelerates innovation and commercialization. Regulatory frameworks, though evolving, provide relatively clearer guidance compared to other regions, supporting adoption. High disposable incomes and willingness to invest in premium health products further strengthen demand.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR by rising focus on preventative health. Countries such as China, India, and Japan are witnessing growing demand for personalized supplements among younger demographics. Expanding middle-class populations and increasing disposable incomes support premium product adoption. Government initiatives promoting innovation in healthcare and nutrition further boost demand. E-commerce platforms are making nutrigenomics-based supplements more accessible across diverse markets. Rising awareness of gene-diet interaction is accelerating adoption, particularly in urban centers.

Key players in the market

Some of the key players in Nutrigenomics-Based Supplements Market include Nutrigenomix, DNAfit Life Sciences, Genova Diagnostics, GX Sciences, Metagenics, Thorne HealthTech, LifeGenomics, GenePlanet, MyDNA, Toolbox Genomics, Vitagene, DayTwo, Habit Personalized Nutrition and Persona Nutrition.

Key Developments:

In August 2025, Genova Diagnostics reported operations across over 10,000 healthcare providers globally, with services spanning North America, Europe, and Asia. This expansion reflects rising demand for nutrigenomics-based supplements and personalized nutrition testing.

In March 2024, DNAfit launched expanded genetic testing panels covering nutrition, fitness, and stress, directly linked to supplement personalization. These offerings allow practitioners and consumers to tailor nutraceuticals to genetic predispositions, reinforcing DNAfit's leadership in personalized health.

Supplement Types Covered:

  • Vitamins & Minerals
  • Probiotics & Prebiotics
  • Omega-3 & Healthy Fats
  • Protein & Amino Acids
  • Specialty Nutraceutical
  • Other Supplement Types

Personalization Approachs Covered:

  • DNA-Based Personalization
  • Microbiome-Based Personalization
  • Lifestyle & Environmental Data Integration
  • AI/ML Algorithm-Driven Personalization
  • Other Personalization Approachs

Distribution Channels Covered:

  • Direct-to-Consumer (D2C) Platforms
  • Pharmacies & Drugstores
  • Specialty Nutrition Stores
  • Online Marketplaces
  • Other Distribution Channels

End Users Covered:

  • Millennials & Gen Z
  • Gen X
  • Baby Boomers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Nutrigenomics-Based Supplements Market, By Supplement Type

  • 5.1 Introduction
  • 5.2 Vitamins & Minerals
  • 5.3 Probiotics & Prebiotics
  • 5.4 Omega-3 & Healthy Fats
  • 5.5 Protein & Amino Acids
  • 5.6 Specialty Nutraceutical
  • 5.7 Other Supplement Types

6 Global Nutrigenomics-Based Supplements Market, By Personalization Approach

  • 6.1 Introduction
  • 6.2 DNA-Based Personalization
  • 6.3 Microbiome-Based Personalization
  • 6.4 Lifestyle & Environmental Data Integration
  • 6.5 AI/ML Algorithm-Driven Personalization
  • 6.6 Other Personalization Approachs

7 Global Nutrigenomics-Based Supplements Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Direct-to-Consumer (D2C) Platforms
  • 7.3 Pharmacies & Drugstores
  • 7.4 Specialty Nutrition Stores
  • 7.5 Online Marketplaces
  • 7.6 Other Distribution Channels

8 Global Nutrigenomics-Based Supplements Market, By End User

  • 8.1 Introduction
  • 8.2 Millennials & Gen Z
  • 8.3 Gen X
  • 8.4 Baby Boomers
  • 8.5 Other End Users

9 Global Nutrigenomics-Based Supplements Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Nutrigenomix
  • 11.2 DNAfit Life Sciences
  • 11.3 Genova Diagnostics
  • 11.4 GX Sciences
  • 11.5 Metagenics
  • 11.6 Thorne HealthTech
  • 11.7 LifeGenomics
  • 11.8 GenePlanet
  • 11.9 MyDNA
  • 11.10 Toolbox Genomics
  • 11.11 Vitagene
  • 11.12 DayTwo
  • 11.13 Habit Personalized Nutrition
  • 11.14 Persona Nutrition

List of Tables

  • Table 1 Global Nutrigenomics-Based Supplements Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Nutrigenomics-Based Supplements Market Outlook, By Supplement Type (2024-2032) ($MN)
  • Table 3 Global Nutrigenomics-Based Supplements Market Outlook, By Vitamins & Minerals (2024-2032) ($MN)
  • Table 4 Global Nutrigenomics-Based Supplements Market Outlook, By Probiotics & Prebiotics (2024-2032) ($MN)
  • Table 5 Global Nutrigenomics-Based Supplements Market Outlook, By Omega-3 & Healthy Fats (2024-2032) ($MN)
  • Table 6 Global Nutrigenomics-Based Supplements Market Outlook, By Protein & Amino Acids (2024-2032) ($MN)
  • Table 7 Global Nutrigenomics-Based Supplements Market Outlook, By Specialty Nutraceutical (2024-2032) ($MN)
  • Table 8 Global Nutrigenomics-Based Supplements Market Outlook, By Other Supplement Types (2024-2032) ($MN)
  • Table 9 Global Nutrigenomics-Based Supplements Market Outlook, By Personalization Approach (2024-2032) ($MN)
  • Table 10 Global Nutrigenomics-Based Supplements Market Outlook, By DNA-Based Personalization (2024-2032) ($MN)
  • Table 11 Global Nutrigenomics-Based Supplements Market Outlook, By Microbiome-Based Personalization (2024-2032) ($MN)
  • Table 12 Global Nutrigenomics-Based Supplements Market Outlook, By Lifestyle & Environmental Data Integration (2024-2032) ($MN)
  • Table 13 Global Nutrigenomics-Based Supplements Market Outlook, By AI/ML Algorithm-Driven Personalization (2024-2032) ($MN)
  • Table 14 Global Nutrigenomics-Based Supplements Market Outlook, By Other Personalization Approachs (2024-2032) ($MN)
  • Table 15 Global Nutrigenomics-Based Supplements Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 16 Global Nutrigenomics-Based Supplements Market Outlook, By Direct-to-Consumer (D2C) Platforms (2024-2032) ($MN)
  • Table 17 Global Nutrigenomics-Based Supplements Market Outlook, By Pharmacies & Drugstores (2024-2032) ($MN)
  • Table 18 Global Nutrigenomics-Based Supplements Market Outlook, By Specialty Nutrition Stores (2024-2032) ($MN)
  • Table 19 Global Nutrigenomics-Based Supplements Market Outlook, By Online Marketplaces (2024-2032) ($MN)
  • Table 20 Global Nutrigenomics-Based Supplements Market Outlook, By Other Distribution Channels (2024-2032) ($MN)
  • Table 21 Global Nutrigenomics-Based Supplements Market Outlook, By End User (2024-2032) ($MN)
  • Table 22 Global Nutrigenomics-Based Supplements Market Outlook, By Millennials & Gen Z (2024-2032) ($MN)
  • Table 23 Global Nutrigenomics-Based Supplements Market Outlook, By Gen X (2024-2032) ($MN)
  • Table 24 Global Nutrigenomics-Based Supplements Market Outlook, By Baby Boomers (2024-2032) ($MN)
  • Table 25 Global Nutrigenomics-Based Supplements Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.